Ossium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood and immune ...

US bioengineering company Ossium Health has treated its first leukaemia patient with cryopreserved organ donor-derived bone marrow as part of its HOPE clinical programme.

President Cal Bradford’s last day on — or rather, under — Earth is the focus of this week’s Paradise, an hour that also sees Xavier officially go rogue. We’ve got a lot of poor-little ...

Ossium Health, Inc. announced today that the California Institute of Regenerative Medicine (CIRM) has awarded the company a $3.46M Clinical Stage Rese ...

Ossium Health launched the HOPE Program, which further expands patient access to Ossium’s bone marrow bank.

Kevin Caldwell, CEO & Co-Founder of Ossium Health, sits down with Nasdaq Listings Host, Kristina Ayanian, to discuss how they develop stem cell-based therapies that are designed to improve the ...

SAN FRANCISCO, September 30, 2024 -- (BUSINESS WIRE)-- Ossium Health, a commercial-stage bioengineering company with the first-of-its-kind bone marrow bank for processing and deploying stem cell ...

U S bioengineering company Ossium Health has treated its first leukaemia patient with cryopreserved organ donor-derived bone marrow as part of its HOPE clinical programme.

US bioengineering company Ossium Health has treated its first leukaemia patient with cryopreserved organ donor-derived bone marrow as part of its HOPE clinical programme.